摘要
现如今肺癌已成为中国乃至全世界范围内头号恶性肿瘤。大多数肺癌患者发现时多处于中晚期阶段,其5年生存率较低。早发现、早治疗能明显提高早期肺癌患者的5年生存率。随着现代检测技术的迅速发展,许多孤立性肺结节患者能够在早期就被发现。但是目前临床上对SPN进行精确的良恶性判断是很困难的。因此,了解孤立性肺小结节诊断和治疗相关进展,对SPN良恶性的鉴别以及早期合理的干预具有重要的意义,这不仅可以提高早期肺癌的检测率,也可以减少不必要的有创操作,减轻患者及家庭的经济负担,同时还可以明显改善患者的预后。
Nowadays, lung cancer is increasing, and it has become the number one malignant tumor allover the world. The 5-year survival rate of most lung cancer patients is very low. However, early treatment can significantly improve the 5-year survival rate of patients with early-stage lung cancer. With the rapid development of modern detection techniques, many patients with solitary pulmonary nodule(SPN) have been discovered at an early stage. But at present, it is very difficult to make accurate diagnosis of benign and malignant SPN. Therefore, understanding the progress of diagnosis and treatment progress of solitary pulmonary nodule is of great significance for the identification and intervention of benign and malignant SPN. Also it can not only improve the detection rate of early lung cancer, but also reduce unnecessary invasive operation and the financial burden of patients and families, and also significantly improve the prognosis of patients.
作者
许海柱
祝佳佳
张栩
XU Haizhu;ZHU Jiajia;ZHANG Xu(Department of Chinese Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China;Department of Pulmonary Disease, Shanghai TCM-Integrated Hospital, Shanghai 200082, China)
出处
《长春中医药大学学报》
2019年第5期1002-1006,共5页
Journal of Changchun University of Chinese Medicine
基金
上海市科委医学引导项目(17401930800)
华东医院第二批优秀青年人才培养计划(HDYQ2017010)
关键词
孤立性肺结节
诊断
中西医治疗方法
进展
solitary pulmonary nodule
diagnosis
treatment of traditional Chinese and Western medicine
progress
